DOI QR코드

DOI QR Code

Erdheim-Chester Disease Involving the Biliary System and Mimicking Immunoglobulin G4-Related Disease: A Case Report

면역글로불린 G4 연관 질환과 유사한 담관 침범을 보이는 Erdheim-Chester 병: 증례 보고

  • Hyuk Gi Hong (Department of Radiology, Seoul Medical Center) ;
  • Yong Eun Chung (Department of Radiology, Severance Hospital, Yonsei University College of Medicine) ;
  • June Park (Department of Radiology, Severance Hospital, Yonsei University College of Medicine) ;
  • Yeo Eun Kim (Department of Radiology, Seoul Medical Center)
  • 홍혁기 (서울의료원 영상의학과) ;
  • 정용은 (연세대학교 의과대학 세브란스병원 영상의학과) ;
  • 박준 (연세대학교 의과대학 세브란스병원 영상의학과) ;
  • 김여은 (서울의료원 영상의학과)
  • Received : 2022.08.16
  • Accepted : 2022.11.13
  • Published : 2023.05.01

Abstract

First described in 1930 as a lipoid granulomatosis, Erdheim-Chester disease (ECD) is a rare histiocytosis encompassing a group of disorders caused by overproduction of histiocytes, a subtype of white blood cells. This disease most commonly involves the bones and can affect organs in the abdomen; however, biliary involvement is rarely reported. We report a case of ECD with biliary involvement, which rendered it difficult to radiologically distinguish ECD from immunoglobulin G4-related disease.

Erdheim-Chester 병은 희귀한 조직구증으로, 백혈구의 아형인 조직구의 과잉 생산으로 인한 질병 중 하나이며, 1930년에 처음 기술되었다. Erdheim-Chester 병은 가장 흔하게는 뼈를 침범하고, 복부의 다른 모든 기관을 침범할 수 있지만 담도 침범의 증례는 매우 드물게 보고된다. 이에 저자는 영상의학적으로 면역글로불린 G4 연관 질환과 구별하기 어려웠던 Erdheim-Chester 질환의 담도 침범 사례를 보고하고자 한다.

Keywords

References

  1. Zaveri J, La Q, Yarmish G, Neuman J. More than just Langerhans cell histiocytosis: a radiologic review of histiocytic disorders. Radiographics 2014;34:2008-2024 
  2. Dion E, Graef C, Haroche J, Renard-Penna R, Cluzel P, Wechsler B, et al. Imaging of thoracoabdominal involvement in Erdheim-Chester disease. AJR Am J Roentgenol 2004;183:1253-1260 
  3. Kumar P, Singh A, Gamanagatti S, Kumar S, Chandrashekhara SH. Imaging findings in Erdheim-Chester disease: what every radiologist needs to know. Pol J Radiol 2018;83:e54-e62 
  4. Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016;127:2672-2681 
  5. Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 2020;135:1929-1945 
  6. Haroche J, Charlotte F, Arnaud L, von Deimling A, Helias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 2012;120:2700-2703 
  7. Lee HJ, Lee KY, Shin DY, Lee YG, Choi SY, Moon KC, et al. A case of Erdheim-Chester disease with asymptomatic renal involvement. Cancer Res Treat 2012;44:146-150 
  8. Gundling F, Nerlich A, Heitland WU, Schepp W. Biliary manifestation of Erdheim-Chester disease mimicking Klatskin's carcinoma. Am J Gastroenterol 2007;102:452-454 
  9. Park K, Choi YW, Kang BK, Lee JY, Park JS, Shin SJ, et al. Systemic manifestations of immunoglobulin G4-related disease: a pictorial essay. J Korean Soc Radiol 2021;82:575-588 
  10. Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. 18F-FDG PET/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker. J Nucl Med 2018;59:774-779